The current study revealed that serum level of hs-CRP ≥ 10 mg/L was associated with a 2.593-fold increase in risk of CAD in type 2 diabetes when compared with hs-CRP level < 10 mg/L. This evidence concerns the gene CRP and coronary artery disorder.